AliHussainAl-KhafajiMD
Internal Medicine • Pittsburgh, PACritical Care Medicine
Professor, Critical Care Medicine and Surgery, University of Pittsburgh School of Medicine
Dr. Al-Khafaji is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Lothrop St
Pittsburgh, PA 15213Phone+1 412-647-3136Fax+1 412-647-4486
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Critical Care Medicine (Internal Medicine), 1999 - 2001
UPMC Medical Education/MercyResidency, Internal Medicine, 1996 - 1999
University of Al-Mustansiriyah College of MedicineClass of 1993
Certifications & Licensure
NH State Medical License 1999 - Present
PA State Medical License 1997 - 2024
FL State Medical License 2019 - 2023
ND State Medical License 2001 - 2002- American Board of Internal Medicine Critical Care Medicine
Clinical Trials
- Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 10 citationsSuccinylcholine-induced hyperkalemia in a patient with mucositis secondary to chemotherapy.Ali Al-Khafaji, William E. Dewhirst, Cornelius J. Cornell, Timothy J. Quill
Critical Care Medicine. 2001-06-01 - 892 citationsDiscovery and validation of cell cycle arrest biomarkers in human acute kidney injury.Kianoush Kashani, Ali Al-Khafaji, Thomas Ardiles, Antonio Artigas, Sean M. Bagshaw
Critical Care. 2013-02-06 - 30 citationsExternal validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injurySean M. Bagshaw, Ali Al-Khafaji, Antonio Artigas, Danielle Davison, Michael Haase
Critical Care. 2021-05-31
Press Mentions
Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion CriteriaNovember 29th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
